11 March 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
12 February 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine ...
18 January 2024 - Draft guidance for public consultation has been published by NICE. ...
15 January 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
11 December 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
13 November 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
9 October 2023 - First and only approved medicine in Scotland which targets germline (hereditary) BRCA mutations in early breast cancer ...
9 October 2023 - The SMC has accepted Aquipta (atogepant), the oral, once daily calcitonin gene-related peptide receptor antagonist for restricted ...
9 October 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
11 September 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
7 August 2023 - Vazkepa already commercially available in England, Wales, and Northern Ireland where NICE recommended its reimbursement and use ...
7 August 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
10 July 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
14 June 2023 - SMC has collaborated with NICE on Technology Appraisal, TA900: tixagevimab-cilgavimab for preventing COVID-19. ...